Alphora Research provides API technology development services for the scale-up of complex small molecules for pharmaceutical applications. Alphora combines excellence and creativity in synthetic organic chemistry with a sound scientific approach to analytical development for novel API technology. Alphora's API development efforts focus from the preclinical stage through to phase III. This focus includes: Synthetic scale-up development Analytical development and validation Stability testing gram to kilogram synthesis, both cGMP and non-GMP Technology transfer services. Alphora Research recently expanded to include a 14,000 sq/ft operating facility and cGMP Pilot Plant. This addition reinforces our capabilities in API Technology Development, ensuring our clients continue to receive "the right development at the right time".
